BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

481 hedge funds and large institutions have $15.3B invested in BioMarin Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 174 increasing their positions, 173 reducing their positions, and 54 closing their positions.

Holders
481
Holders Change
-3
Holders Change %
-0.62%
% of All Funds
10.46%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.22%
New
57
Increased
174
Reduced
173
Closed
54
Calls
$106M
Puts
$168M
Net Calls
-$62.3M
Net Calls Change
-$19.8M

Top Buyers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$258M
2
PHS
2
PFM Health Sciences
California
$178M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$1.69B
4
YCMGA
4
York Capital Management Global Advisors
New York
$95.6M
5
ACA
5
Avoro Capital Advisors
New York
$181M

Top Sellers

1
Jennison Associates
1
Jennison Associates
New York
$809M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$222M
3
WRF
3
Waddell & Reed Financial
Kansas
$65.3M
4
PI
4
Putnam Investments
Massachusetts
$0
5
Massachusetts Financial Services
5
Massachusetts Financial Services
Massachusetts
$28.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.69B 19,696,205 +1,947,144 +11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.37B 15,957,672 +247,798 +2%
Primecap Management
3
Primecap Management
California
$1.22B 14,283,753 +92,880 +0.7%
BlackRock
4
BlackRock
New York
$1.1B 12,860,071 +196,702 +2%
Jennison Associates
5
Jennison Associates
New York
$809M 9,447,815 -2,964,778 -24%
BBA
6
Baker Bros. Advisors
New York
$650M 7,589,294 – –
ClearBridge Investments
7
ClearBridge Investments
New York
$512M 5,974,274 +968,956 +19%
Sands Capital Management
8
Sands Capital Management
Virginia
$491M 5,731,963 -149,483 -3%
State Street
9
State Street
Massachusetts
$402M 4,689,340 +53,188 +1%
Nuveen Asset Management
10
Nuveen Asset Management
Illinois
$258M 3,012,896 +3,012,896 New
Ameriprise
11
Ameriprise
Minnesota
$247M 2,888,393 +235,219 +9%
Invesco
12
Invesco
Georgia
$244M 2,845,836 -622,286 -18%
PAI
13
Palo Alto Investors
California
$223M 2,606,485 -35,000 -1%
Viking Global Investors
14
Viking Global Investors
Connecticut
$222M 2,590,351 -2,538,558 -49%
Capital World Investors
15
Capital World Investors
California
$208M 2,426,082 +872,055 +56%
Temasek Holdings
16
Temasek Holdings
Singapore
$203M 2,372,712 – –
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$197M 2,296,204 -185,337 -7%
ACA
18
Avoro Capital Advisors
New York
$181M 2,115,000 +995,000 +89%
PHS
19
PFM Health Sciences
California
$178M 2,079,388 +2,079,388 New
Goldman Sachs
20
Goldman Sachs
New York
$169M 1,967,615 -207,951 -10%
Bank of America
21
Bank of America
North Carolina
$158M 1,849,241 -57,983 -3%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$155M 1,806,879 +52,797 +3%
Capital International Investors
23
Capital International Investors
California
$154M 1,801,483 +24,664 +1%
Norges Bank
24
Norges Bank
Norway
$149M 1,737,325 +256,507 +17%
Deutsche Bank
25
Deutsche Bank
Germany
$136M 1,582,392 +189,620 +14%
1
2 3 4 5